Grants Management & Research Funding

Grants management is the administrative discipline that carries a piece of research from an idea into a funded, compliant, closed-out award. It spans four broad phases — pre-award proposal development, award negotiation, post-award financial and programmatic administration, and closeout — and it sits at the intersection of institutional policy, sponsor regulation, and federal or international law. A research administrator working in this space needs fluency in cost principles under 2 CFR 200 (the U.S. Uniform Guidance), sponsor-specific mechanics from NIH and NSF to UKRI, the Horizon Europe framework programme, Canada’s Tri-Agency (CIHR, NSERC, SSHRC), and Australia’s ARC and NHMRC — and the audit and compliance obligations that follow public money through an institution. This hub collects CASRAI’s current grants-management guidance and vocabulary and links out to the primary sources that actually govern the work, rather than restating them informally.

The grants management lifecycle: pre-award to closeout

Institutions typically organize sponsored-programs work around the same four phases regardless of funder: a pre-award phase covering opportunity identification through the proposal phase and submission; an award phase covering acceptance of a prime award and negotiation of its terms; a post-award phase covering budget execution, reporting, and compliance monitoring for the life of the project; and a closeout phase once the period of performance ends. Many institutions split staffing along this line too — CASRAI’s Pre-Award vs. Post-Award Office Roles guide covers how the functions typically split, and Departmental vs. Central Sponsored Programs Office covers the parallel question of where in the org chart that work sits. For a plain description of the job itself, see What a Research Administrator Does.

Funding mechanisms: reading a NOFO, an RFA, and a grant activity code

A research funder announces opportunities under a taxonomy of instrument types that determines eligibility, review process, and deadline structure before a proposal is ever written. U.S. federal agencies distinguish a general Notice of Funding Opportunity (NOFO) or Funding Opportunity Announcement (FOA) from a Request for Applications (RFA) — a one-time, set-aside-funded competition with its own receipt date and dedicated review panel — and from a standing Program Announcement. Awards are further split into a competitive grant, evaluated against other applications in the same round, or a non-competitive grant issued under statutory or formula authority. NIH layers a further activity-code taxonomy on top of this — R01, R21, R03, U01, and the K99/R00 Pathway to Independence Award each carry distinct budget caps, review criteria, and eligibility rules that a proposal has to match before a program officer will even triage it. Funding itself can also come from a private foundation grant, endowment income, or increasingly crowdfunded research, each carrying different reporting and IP expectations than a federal award.

Budgeting and cost principles: direct costs, F&A, and cost share

Every federal budget separates direct costs — personnel, equipment, and travel costs specifically identifiable to the project — from indirect costs (F&A), the institution’s negotiated recovery for facilities and administration. The F&A rate is applied to a Modified Total Direct Cost (MTDC) base under 2 CFR 200 Appendix III, and an institution with no negotiated rate can instead elect the de minimis rate under 2 CFR 200.414(f). CASRAI’s NIH Modular Budgets guide and Budget Justification Narrative guide cover how these figures actually get built into a proposal — NIH’s modular budget format applies below $250,000 in direct costs per period, excluding consortium F&A. Cost sharing adds a further layer: a mandatory cost share is a sponsor-required match, a voluntary cost share is offered by the institution, and both must be tracked separately from unrecovered indirect cost recovery. A February 2025 NIH notice (NOT-OD-25-068) attempted to replace individually negotiated F&A rates with a flat 15% cap; CASRAI’s NIH’s Proposed 15% Indirect Cost Cap guide covers the policy and the litigation that has kept it from taking effect as of mid-2026.

Award negotiation, subawards, and post-award administration

Not every sponsored project is a grant. A sponsored research agreement can be structured as a grant, a contract, or a cooperative agreement — the last distinguished by the funding agency’s statutory right of “substantial involvement” in carrying out the work, not just monitoring it. CASRAI’s Grant vs. Contract vs. Cooperative Agreement comparison lays out exactly where the legal tests diverge. Multi-institution work adds a consortium agreement layer: the lead institution holds the prime award as a pass-through entity and issues a subaward to each partner, which 2 CFR 200.331 classifies as either a subrecipient or a contractor based on the substance of the relationship, not the label on the document — see CASRAI’s Subrecipient vs. Contractor vs. Vendor comparison. The Federal Demonstration Partnership, a consortium of 230+ U.S. institutions and federal agencies, publishes standardized Cost Reimbursement, Fixed Amount, and Foreign subaward templates that many institutions use as-is rather than drafting from scratch — CASRAI’s FDP Subaward Templates guide and Subaward Agreement Negotiation guide cover the mechanics, including the pass-through entity’s ongoing subrecipient monitoring obligation under 2 CFR 200.332. A pass-through entity may also issue a fixed-amount subaward — capped at $500,000 per award since OMB’s April 2024 Uniform Guidance revision — without the sponsor’s ordinary cost-reimbursement documentation burden.

Once an award is active, financial administration runs on its own reporting calendar. An annual report covers each reporting period; the project closes with a final report and a financial report — for most U.S. federal awards, the SF-425 Federal Financial Report. NIH-funded projects file a Research Performance Progress Report (RPPR) on the same cadence. Day-to-day management tracks burn rate against the budget and resolves any underspend or encumbrance for costs committed but not yet paid. A project running behind schedule but not over budget can typically request a no-cost extension (NCE) rather than forfeit unspent funds, and unobligated balances can sometimes be requested as carry-forward into the next budget period. Award payment itself follows one of several models, including milestone payment, fixed-price, and cost-reimbursement structures, and a project nearing its natural end may be extended as a continuation or renewable award rather than recompeted from scratch. Not every award reaches a clean end: a sponsor can invoke a formal termination or suspension for cause, each with its own notice and appeal rights under 2 CFR 200.340–.342.

Compliance, audit, and risk

Federal funding carries audit exposure that scales with an institution’s total federal expenditure. Since OMB’s April 2024 Uniform Guidance revision, an entity that spends $1,000,000 or more in federal awards in a fiscal year (raised from the prior $750,000 threshold) must undergo a Single Audit under 2 CFR Part 200 Subpart F, and 2 CFR 200.303 requires the entity to maintain internal controls aligned to the GAO Green Book or COSO framework and to act promptly on any finding. Institutions also disclose their cost-accounting practices to their cognizant federal agency on a DS-2 Disclosure Statement before charging costs inconsistently with it, and every organization or individual named on a federal award should be screened against SAM.gov exclusions — see CASRAI’s debarment and suspension verification term. CASRAI’s Federal Grant Compliance Checklist, Institutional Internal Controls for Federal Grant Compliance, and Federal Grant Closeout guides walk through the practical mechanics — closeout itself runs on a hard 120-calendar-day deadline under 2 CFR 200.344. The stakes are real: misrepresenting compliance with grant terms, mischarging costs, or fabricating data underlying a federal application can trigger a False Claims Act action, including a qui tam suit brought by a whistleblower entitled to a share of any recovery — Duke University’s 2019 settlement of False Claims Act allegations tied to federal research grants, at $112.5 million, remains one of the largest in the area. Related institutional obligations that touch the same award file include conflict-of-interest disclosure, material transfer agreements for shared research materials, and, for internationally collaborative awards, export control (EAR/ITAR) review.

International research funding: UK, EU, Canada, and Australia

Outside the U.S. federal system, the same lifecycle runs under different costing and governance logic. UK institutions cost proposals to research councils on a full economic costing (fEC) basis using the Transparent Approach to Costing (TRAC) methodology, and UKRI funds at 80% of fEC — the institution absorbs the remaining 20% as its own contribution, which changes how a UK proposal budget gets built compared with a U.S. one. The Horizon Europe programme instead applies a flat 25% indirect-cost rate on top of eligible direct costs, reimbursed at rates that vary by action type, and has progressively expanded lump-sum funding — the European Commission reports roughly half of 2026–2027 Work Programme calls use a fixed, deliverable-triggered lump-sum grant rather than actual-cost reimbursement. A Horizon Europe grant agreement assigns each partner a role — coordinator, beneficiary, or associated partner — with work organized into numbered tasks against agreed deliverables. Canada’s three federal granting agencies (CIHR, NSERC, and SSHRC) jointly publish the Tri-Agency Guide on Financial Administration (TAGFA), a principles-based framework governing how grant funds may be used across all three agencies, with a revised edition taking effect April 1, 2026. Australia runs two parallel national schemes with their own submission systems: the Australian Research Council’s National Competitive Grants Program through its Research Management System (RMS), and the National Health and Medical Research Council’s schemes — including its Investigator Grants — through the Sapphire platform, which has replaced the older RGMS system. A comparison worth reading alongside this section: CASRAI’s NIH Biosketch vs. UKRI R4RI, on how the two systems’ narrative-CV formats differ, and its NIH vs. NSF vs. ERC comparison of generative-AI policy in proposal writing across three major funders. Cross-border projects that move funding between national funders raise their own knowledge exchange and reporting questions that CASRAI is still building out coverage for (see below).

Career-stage and training-grant funding, and where this cluster connects

A distinct sub-track of grants management covers funding tied to a researcher’s career stage rather than a project: NIH’s K99/R00 Pathway to Independence Award (covered in CASRAI’s dedicated guide above) is one of several career-development mechanisms alongside F31/F32 fellowships and T32 institutional training grants, each with its own eligibility, stipend, and reporting rules layered on top of the standard federal grant framework. Proposal and application packages for these mechanisms lean heavily on a candidate’s NIH-style biosketch, personal statement, and increasingly a narrative CV format — the international counterpart research administrators should know is UKRI’s Résumé for Research and Innovation (R4RI), covered in the comparison linked above. Administrators tracking who is eligible to serve as a Principal Investigator on a given mechanism also need to distinguish a post-doctoral researcher from a pre-doctoral researcher for eligibility and reporting purposes, and NIH-funded proposals require Other Support disclosures in a specific NIH format at just-in-time and progress-report stages. This cluster connects outward in several directions: cost-share and effort questions overlap with CASRAI’s Research Integrity & Compliance hub (which currently hosts several of the guides linked above), Data Management Plan requirements at proposal stage connect to the Research Data Management hub, and funder and award identifiers connect to Research Information & Identifiers. A federal award that produces a patentable invention also triggers Bayh-Dole invention-reporting obligations under 37 CFR 401.14 — the boundary where grants management hands off to a university’s technology-transfer office. Publication costs incurred under a grant, including APC reimbursement for an open-access publication cost, are themselves a grant-eligible cost category most funders now recognize explicitly.

What’s covered here so far

This is a newer CASRAI cluster, and its live content is still thin relative to the scope above. Two dedicated guides exist today — the K99/R00 mechanism and the NIH RFA process — plus a substantial set of grants-management-relevant guides currently organized under CASRAI’s compliance cluster (linked throughout the sections above) and roughly sixty dictionary terms in the funding lifecycle and financial vocabulary domain. Priority gaps the pipeline is aware of and actively drafting toward: dedicated guides on F&A rate negotiation with a cognizant agency, the NSF PAPPG budget process end-to-end, Horizon Europe consortium building and the DESCA model agreement, Tri-Agency TAGFA in practice, and the professional-credentialing landscape for research administrators — NCURA and SRA International in the U.S., and RACC’s CRA, CPRA, and CFRA certifications specifically. As with every CASRAI cluster, this page is designed to accumulate more links as that content goes live, not to stand as a finished inventory.

Frequently asked questions

What’s the difference between a grant, a contract, and a cooperative agreement?

All three fund research, but the legal test is purpose and involvement, not the label on the paperwork. A grant transfers funds for a public purpose with minimal agency involvement in carrying out the work; a cooperative agreement is the same but with the agency retaining a statutory right of “substantial involvement”; a contract is used when the agency’s principal purpose is acquiring a good or service for its own direct benefit. See CASRAI’s Grant vs. Contract vs. Cooperative Agreement comparison for the full breakdown.

Is F&A the same thing as overhead?

Functionally, yes — F&A (Facilities & Administrative costs) is the federal cost-principles term for what is colloquially called overhead: costs that benefit multiple projects (building depreciation, utilities, central administration) and so can’t be charged as a direct cost to any single one. An institution’s F&A rate is individually negotiated with its cognizant federal agency and applied to a defined base, usually Modified Total Direct Costs.

What triggers a Single Audit?

Spending $1,000,000 or more in federal awards in a fiscal year, as of OMB’s April 2024 Uniform Guidance revision (the threshold was previously $750,000). The audit, required under 2 CFR Part 200 Subpart F, covers both the institution’s financial statements and its compliance with the specific requirements attached to each major federal program.

Does a subrecipient get the same compliance treatment as a vendor?

No, and getting this classification wrong is a common audit finding. A subrecipient carries out a substantive portion of the funded project under its own programmatic decision-making and is subject to full flow-down of applicable award terms and ongoing subrecipient monitoring; a contractor (the current 2 CFR 200.331 term for what used to be called a vendor) simply provides goods or services within its normal business operations and is not subject to those same compliance requirements. See CASRAI’s Subrecipient vs. Contractor vs. Vendor comparison.

Why do UK and EU grants use such different cost models from U.S. federal grants?

Each system built its costing rules around a different policy goal. The U.S. Uniform Guidance requires actual, auditable direct and indirect costs tied to an individually negotiated F&A rate. The UK’s fEC/TRAC model funds a fixed 80% of a nationally standardized full-cost calculation, shifting the remaining 20% onto the institution by design. Horizon Europe increasingly uses flat-rate and lump-sum funding specifically to reduce the actual-cost audit burden on multinational consortia, at the cost of less precise cost recovery for any single partner.